Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects against heart failure via increasing epoxyeicosatrienoic acids - Journal of Molecular and Cellular Cardiology

October 06,2024

JCI - Soluble epoxide hydrolase promotes astrocyte survival in

Discovery of Novel Soluble Epoxide Hydrolase Inhibitors as Potent

Screening and Biological Evaluation of Soluble Epoxide Hydrolase

Epoxyeicosatrienoic acids and soluble epoxide hydrolase in

Discovery of Novel Soluble Epoxide Hydrolase Inhibitors as Potent

Journal of Molecular and Cellular Cardiology

High-fat feeding in cardiomyocyte-restricted PPARδ knockout mice

Epoxyeicosatrienoic Acid as Therapy for Diabetic and Ischemic

Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects

Cardiomyocyte-specific disruption of soluble epoxide hydrolase

Innate Immune Nod1/RIP2 Signaling Is Essential for Cardiac

Soluble epoxide hydrolase inhibition and gene deletion are